Financhill
Sell
29

ZTS Quote, Financials, Valuation and Earnings

Last price:
$127.26
Seasonality move :
1.3%
Day range:
$125.47 - $129.98
52-week range:
$115.25 - $177.00
Dividend yield:
1.57%
P/E ratio:
21.44x
P/S ratio:
6.05x
P/B ratio:
16.36x
Volume:
4.5M
Avg. volume:
4.8M
1-year change:
-17.48%
Market cap:
$54.5B
Revenue:
$9.5B
EPS (TTM):
$6.02

Analysts' Opinion

  • Consensus Rating
    Zoetis, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $151.00, Zoetis, Inc. has an estimated upside of 16.94% from its current price of $129.13.
  • Price Target Downside
    According to analysts, the lowest downside price target is $130.00 representing -0.67% downside risk from its current price of $129.13.

Fair Value

  • According to the consensus of 16 analysts, Zoetis, Inc. has 16.94% upside to fair value with a price target of $151.00 per share.

ZTS vs. S&P 500

  • Over the past 5 trading days, Zoetis, Inc. has overperformed the S&P 500 by 0.12% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Zoetis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Zoetis, Inc. has grown year-over-year revenues for 40 quarters straight. In the most recent quarter Zoetis, Inc. reported revenues of $2.4B.

Earnings Growth

  • Zoetis, Inc. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Zoetis, Inc. reported earnings per share of $1.37.
Enterprise value:
61.5B
EV / Invested capital:
4.87x
Price / LTM sales:
6.05x
EV / EBIT:
17.10x
EV / Revenue:
6.50x
PEG ratio (5yr expected):
2.11x
EV / Free cash flow:
26.94x
Price / Operating cash flow:
25.10x
Enterprise value / EBITDA:
15.06x
Gross Profit (TTM):
$6.7B
Return On Assets:
18.2%
Net Income Margin (TTM):
28.24%
Return On Equity:
57.78%
Return On Invested Capital:
22.26%
Operating Margin:
34.6%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $8.5B $9.3B $9.5B $2.3B $2.4B
Gross Profit $5.8B $6.4B $6.7B $1.6B $1.6B
Operating Income $3.1B $3.4B $3.6B $765M $826M
EBITDA $3.6B $3.9B $4.1B $888M $947M
Diluted EPS $5.07 $5.47 $6.02 $1.29 $1.37
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $6.9B $7.5B $6.3B $6B $6.8B
Total Assets $13.9B $14.9B $14.3B $14.2B $15.5B
Current Liabilities $1.8B $3.2B $1.9B $3.4B $2.2B
Total Liabilities $9.4B $10.5B $9.3B $9.5B $12.1B
Total Equity $4.5B $4.4B $5B $4.8B $3.3B
Total Debt $6.7B $8.1B $6.8B $6.7B $9.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $2.4B $3B $2.9B $905M $893M
Cash From Investing -$777M -$315M -$748M $126M -$166M
Cash From Financing -$3.1B -$2.7B -$1.9B -$745M -$495M
Free Cash Flow $1.6B $2.3B $2.3B $689M $732M
ZTS
Sector
Market Cap
$54.5B
$25.8M
Price % of 52-Week High
72.96%
48.88%
Dividend Yield
1.57%
0%
Shareholder Yield
6.69%
-1.67%
1-Year Price Total Return
-17.48%
-21.92%
Beta (5-Year)
0.962
0.499
Dividend yield:
1.57%
Annualized payout:
$2.00
Payout ratio:
38.55%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $127.31
200-day SMA
Sell
Level $142.63
Bollinger Bands (100)
Sell
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Buy
Level $125.51
Relative Strength Index (RSI14)
Buy
Level 53.43
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -24.797
50-day SMA
Buy
Level $124.38
MACD (12, 26)
Buy
Level 10.30
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level --

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.6185)
Buy
CA Score (Annual)
Level (-0.1668)
Buy
Beneish M-Score (Annual)
Level (-2.4492)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.1804)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Stock Forecast FAQ

In the current month, ZTS has received 7 Buy ratings 9 Hold ratings, and 0 Sell ratings. The ZTS average analyst price target in the past 3 months is $151.00.

  • Where Will Zoetis, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Zoetis, Inc. share price will rise to $151.00 per share over the next 12 months.

  • What Do Analysts Say About Zoetis, Inc.?

    Analysts are divided on their view about Zoetis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Zoetis, Inc. is a Sell and believe this share price will drop from its current level to $130.00.

  • What Is Zoetis, Inc.'s Price Target?

    The price target for Zoetis, Inc. over the next 1-year time period is forecast to be $151.00 according to 16 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.

  • Is ZTS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Zoetis, Inc. is a Hold. 9 of 16 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of ZTS?

    You can purchase shares of Zoetis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Zoetis, Inc. shares.

  • What Is The Zoetis, Inc. Share Price Today?

    Zoetis, Inc. was last trading at $127.26 per share. This represents the most recent stock quote for Zoetis, Inc.. Yesterday, Zoetis, Inc. closed at $129.13 per share.

  • How To Buy Zoetis, Inc. Stock Online?

    In order to purchase Zoetis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
46
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
23
CAR alert for Feb 20

Avis Budget Group, Inc. [CAR] is down 21.87% over the past day.

Buy
75
HYMC alert for Feb 20

Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.

Sell
1
EPAM alert for Feb 20

EPAM Systems, Inc. [EPAM] is down 16.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock